Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Waldmann

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
European Journal of Immunology|June 9, 2012
Activation rather than Foxp3 expression determines that TGF-β-induced regulatory T cells out-compete naïve T cells in dendritic cell clusteringYe Chen, Elizabeth Adams, Frederico S Regateiro, et al.
British Journal of Haematology|April 3, 2003
T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survivalSuparno Chakrabarti, Dorothy MacDonald, Geoff Hale, et al.
Immunology|March 6, 2010
Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibodyJose F Ponte, Paul Ponath, Reema Gulati, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Induction of immunological tolerance/hyporesponsiveness in baboons with a nondepleting CD4 antibodyDawn Winsor-Hines, Christopher Merrill, Mark O'Mahony, et al.
Transplantation|April 9, 2009
Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-upMenna R Clatworthy, Peter J Friend, Roy Y Calne, et al.
Diabetes|April 28, 2005
Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cellsSylvaine You, Mériam Belghith, Stephen Cobbold, et al.
Journal of Leukocyte Biology|May 27, 2010
Tmem176B and Tmem176A are associated with the immature state of dendritic cellsThomas Condamine, Laetitia Le Texier, Duncan Howie, et al.
Human Gene Therapy|November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockadeSang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
European Journal of Immunology|June 9, 2012
Activation rather than Foxp3 expression determines that TGF-β-induced regulatory T cells out-compete naïve T cells in dendritic cell clusteringYe Chen, Elizabeth Adams, Frederico S Regateiro, et al.
British Journal of Haematology|April 3, 2003
T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survivalSuparno Chakrabarti, Dorothy MacDonald, Geoff Hale, et al.
Immunology|March 6, 2010
Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibodyJose F Ponte, Paul Ponath, Reema Gulati, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Induction of immunological tolerance/hyporesponsiveness in baboons with a nondepleting CD4 antibodyDawn Winsor-Hines, Christopher Merrill, Mark O'Mahony, et al.
Transplantation|April 9, 2009
Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-upMenna R Clatworthy, Peter J Friend, Roy Y Calne, et al.
Diabetes|April 28, 2005
Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cellsSylvaine You, Mériam Belghith, Stephen Cobbold, et al.
Journal of Leukocyte Biology|May 27, 2010
Tmem176B and Tmem176A are associated with the immature state of dendritic cellsThomas Condamine, Laetitia Le Texier, Duncan Howie, et al.
Human Gene Therapy|November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockadeSang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Pageof 16